Net Cash Provided by (Used in) Operating Activities |
381K |
USD |
-32.9% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
16K |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
7.68M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
397K |
USD |
|
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
7.63M |
USD |
+12.1% |
Q2 2024 |
Q2 2024 |
Property, Plant and Equipment, Gross |
27M |
USD |
+0.89% |
Q2 2024 |
Q2 2024 |
Deferred Income Tax Expense (Benefit) |
-89K |
USD |
-137% |
Q2 2024 |
Q2 2024 |
Deferred Federal Income Tax Expense (Benefit) |
121K |
USD |
|
Q4 2023 |
FY 2023 |
Additional Paid in Capital |
943K |
USD |
0% |
Q2 2024 |
Q2 2024 |
Current Federal Tax Expense (Benefit) |
-60K |
USD |
-453% |
Q2 2024 |
Q2 2024 |
Depreciation, Depletion and Amortization |
264K |
USD |
+294% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
306K |
USD |
|
Q4 2023 |
FY 2023 |